Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Safety of High Pressure Post-dilation in Bioresorbable Scaffolds

Original Title: Is High Pressure Postdilation Safe in Bioresorbable Vascular Scaffolds? Optical Coherence Tomography Observations After Noncompliant Balloons Inflated at More than 24 Atmospheres.
Reference: Enrico Fabris et al. Catheter Cardiovasc Interv. 2016 Apr;87(5):839-46.

Courtesy of Dr. José Amadeo Guillermo Álvarez.

The mechanical properties of bioresorbable vascular scaffolds (BVS) are different from those of bare metal stents (BMS); given the risk of BVS fracture, high pressure post-dilation is not recommended. However, a thrombosis rate somewhat higher to that of new generation BMS suggests that, in addition to the correct preparation of the plate, it would be necessary some kind of post-dilation to optimize strut apposition and geometry.

The present publication analyzes optical coherence tomography images (OCT) from 22 Absorb bioresorbable scaffolds (Abbott Vascular, Santa Clara California) in 20 lesions from 16 patients undergoing post dilation with non- compliant balloons to 28 ±3.8 atm (range 24 to 40 atm), with a scaffold / balloon diameter/reference vessel diameter ratio of 1.02±0.11. 41% of cases, received high pressure balloons OPN NC (SIS Medical AG, Winterthur, Switzerland) at maximal pressure 30±4.7 atm.

Treated lesions were more complex than those habitually treated with this kind of scaffolds: 35% had moderate to severe calcification (by angiography), 20% involved bifurcation and 55% were ACC/AHA type C.

At final evaluation, there were no fractured devices, there was low residual stenosis area (16±9.6%) with minimal lumen area (OCT) of 5.5±1.4mm2 and only one case of dissected edge (4.5%) that did not require reintervention.

Conclusion
In the context of more complex lesions, post-dilation of bioresorbable scaffolds Absorb with very low compliance balloons and high pressure, with the adequate diameter/ scaffold/ balloon ratio, is safe, since there were no fractured scaffolds and expansion and apposition parameters are comparable to those obtained with less complex lesions.

Editorial Comment
High pressure post dilation has drastically reduced BMS subacute thrombosis rate; however, given the risk of fracture, there are concerns about using this technique with BVS. This is the first study to assess the Absorb BVS integrity after high pressure dilation in vivo and with OCT.

This study analyzed more complex lesions than those habitually treated with these devices, at extremely elevated pressure, with a high percentage of very low compliance balloons.

Outcomes show structure integrity and good area and apposition parameters and, even though further research and clinical follow up is necessary, post dilation could contribute to improve outcomes with this kind of scaffolds.

Courtesy of Dr. José Amadeo Guillermo Álvarez.
Chief of Hemodynamics and Interventional Cardiology at Buenos Aires German Hospital and Buenos Aires British Hospital, Argentina.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...